CRYPTIVAX Trademark

Trademark Overview

On Thursday, April 3, 2025, a trademark application was filed for CRYPTIVAX with the United States Patent and Trademark Office. The USPTO has given the CRYPTIVAX trademark a serial number of 99118774. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 3, 2025. This trademark is owned by Epitopea Inc.. The CRYPTIVAX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Immunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders

Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use

Research and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing information and data relating to oncology and immunology; advisory and consultancy services related to oncology and immunology
cryptivax

General Information

Serial Number99118774
Word MarkCRYPTIVAX
Filing DateThursday, April 3, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesImmunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders
Goods and ServicesActive chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use
Goods and ServicesResearch and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing information and data relating to oncology and immunology; advisory and consultancy services related to oncology and immunology

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEpitopea Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge CB12LA
GB
Party NameEpitopea Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontreal, QC H3T1J4

Trademark Events

Event DateEvent Description
Thursday, April 3, 2025NEW APPLICATION ENTERED
Thursday, April 3, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

cryptivax research medical purposes cancer vaccines pharmaceutical scientific system field services